Published May 31, 2022

Extraordinary leaps need solid foundations, part 2, w/Moderna CEO Stéphane Bancel

Moderna CEO Stéphane Bancel discusses how strategic partnerships and agile networks were crucial in the rapid development of the COVID-19 vaccine, emphasizing the transformative potential of mRNA technology and the future of medicine, while navigating pandemic challenges and championing global cooperation.
Episode Highlights
Masters of Scale logo

Popular Clips

Episode Highlights

  • Partnerships

    The development of Moderna's COVID-19 vaccine was a testament to the power of strategic partnerships. highlights the crucial role of the U.S. government in funding clinical trials, which allowed the vaccine data to be shared globally, benefiting countries like Japan and those in Europe 1. This collaboration was essential in overcoming financial hurdles, as of Morgan Stanley stepped in to support the vaccine's production by purchasing all the stock, thus saving time and resources 1.

    We offer the discount of a billion dollar to the US government because we say, look, if we're going to make money out of this thing, we need to come even.

    ---

    The agility of networks like the US Digital Response further exemplifies how open, voluntary collaborations can pivot to meet new challenges, such as delivering vaccines at scale 2.

       

    Network Activation

    The rapid mobilization of networks was key in addressing the pandemic's challenges. recalls the moment he first learned of the virus in Wuhan and immediately activated his global network of scientists, including , to gather insights 3. This swift communication allowed Moderna to stay ahead of the curve, even when many were skeptical of the virus's potential impact 4.

    I call my team in Boston and, like, it's gonna be a pandemic, and they really think I'm crazy.

    ---

    The foresight of experts like further underscores the importance of trusted networks in recognizing and responding to emerging threats 4.

Related Episodes